Page last updated: 2024-10-30

meclofenoxate and Diabetes Insipidus, Neurogenic

meclofenoxate has been researched along with Diabetes Insipidus, Neurogenic in 1 studies

Meclofenoxate: An ester of DIMETHYLAMINOETHANOL and para-chlorophenoxyacetic acid.

Diabetes Insipidus, Neurogenic: A genetic or acquired polyuric disorder caused by a deficiency of VASOPRESSINS secreted by the NEUROHYPOPHYSIS. Clinical signs include the excretion of large volumes of dilute URINE; HYPERNATREMIA; THIRST; and polydipsia. Etiologies include HEAD TRAUMA; surgeries and diseases involving the HYPOTHALAMUS and the PITUITARY GLAND. This disorder may also be caused by mutations of genes such as ARVP encoding vasopressin and its corresponding neurophysin (NEUROPHYSINS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LAMBUSIER, P1

Other Studies

1 other study available for meclofenoxate and Diabetes Insipidus, Neurogenic

ArticleYear
[ACTION OF CENTROPHENOXINE ON SOME HYPOTHALAMO-HYPOPHYSIAL SYNDROMES].
    La Presse medicale, 1964, May-16, Volume: 72

    Topics: Central Nervous System Stimulants; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Female; Human

1964